Current Status and Future Directions of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Ovarian Cancer

Sep 27, 2017 by in ONCOLOGY Comments Off on Current Status and Future Directions of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Ovarian Cancer

Epithelial ovarian cancer is a peritoneal surface malignancy that most often presents with spread of disease within the peritoneal cavity. Overall 5-year survival is around 50% and progress in improving…

read more

Peritoneal Mesothelioma

Sep 27, 2017 by in ONCOLOGY Comments Off on Peritoneal Mesothelioma

Peritoneal mesothelioma is a rare malignancy where life expectancy with systemic chemotherapy remains poor. Most patients with this disease are diagnosed late with extensive peritoneal disease burden leading to nausea,…

read more

Pharmacology of Perioperative Intraperitoneal and Intravenous Chemotherapy in Patients with Peritoneal Surface Malignancy

Sep 27, 2017 by in ONCOLOGY Comments Off on Pharmacology of Perioperative Intraperitoneal and Intravenous Chemotherapy in Patients with Peritoneal Surface Malignancy

Peritoneal surface malignancy is a common manifestation of intra-abdominal malignancies. Systemic chemotherapy offers no long-term survival and poor quality of life for these patients in their terminal stages of disease….

read more

The Importance of the Learning Curve and Surveillance of Surgical Performance in Peritoneal Surface Malignancy Programs

Sep 27, 2017 by in ONCOLOGY Comments Off on The Importance of the Learning Curve and Surveillance of Surgical Performance in Peritoneal Surface Malignancy Programs

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are complex procedures with a very steep a learning curve (LC). This study evaluates the LC of CRS and HIPEC in a…

read more

Hyperthermic Intraperitoneal Chemotherapy

Sep 27, 2017 by in ONCOLOGY Comments Off on Hyperthermic Intraperitoneal Chemotherapy

Several methods of delivering hyperthermic intraperitoneal chemotherapy (HIPEC) during the course of cytoreductive surgery have been described, but no significant differences in treatment results have been found among them. HIPEC…

read more
Get Clinical Tree app for offline access